Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Petrini · SciRah

Researcher profile · Semantic Scholar

I. Petrini

Share profile

I. Petrini — researcher profile on SciRah

h-index: 33
Works: 141
Citations: 3,650

Most-cited papers

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors
I. Petrini, P. Meltzer, In-Kyu Kim, M. Lucchi +18 more
2014Nature Genetics249 citations Open access
Semantic Scholar
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
M. Del Re, R. Marconcini, Giulia Pasquini, E. Rofi +11 more
2018British Journal of Cancer229 citations Open access
Semantic Scholar
Mutations of epigenetic regulatory genes are common in thymic carcinomas
Yi-Song Wang, Anish Thomas, C. Lau, A. Rajan +8 more
2014Scientific Reports132 citations Open access
Semantic Scholar
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer
Harvey R. Fernandez, Shreyas Gadre, Ming-Jun Tan, G. Graham +16 more
2018Cell Death and Differentiation131 citations Open access
Semantic Scholar
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
E. Katsman, Shari Orlanski, Filippo Martignano, Ilana Fox-Fisher +7 more
2021bioRxiv110 citations Open access
Semantic Scholar
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.
S. Crucitta, F. Cucchiara, R. Mathijssen, J. Mateo +8 more
2022Cancer Treatment Reviews93 citations Open access
Semantic Scholar
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
M. Del Re, M. Tiseo, P. Bordi, A. D’Incecco +17 more
2016OncoTarget87 citations Open access
Semantic Scholar
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy
M. Del Re, S. Crucitta, Giulia Gianfilippo, A. Passaro +8 more
2019International Journal of Molecular Sciences74 citations Open access
Semantic Scholar
Biology of MET: a double life between normal tissue repair and tumor progression.
I. Petrini
2015Annals of Translational Medicine70 citations
Semantic Scholar
Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells
S. Pacini, I. Petrini
2014Front. Cell Dev. Biol.58 citations Open access
Semantic Scholar
Implications of KRAS mutations in acquired resistance to treatment in NSCLC
M. Del Re, E. Rofi, G. Restante, S. Crucitta +5 more
2015OncoTarget53 citations Open access
Semantic Scholar
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK‐Positive NSCLC With Disease Progression During Crizotinib Treatment
P. Bordi, M. Tiseo, E. Rofi, I. Petrini +3 more
2017Clinical Lung Cancer52 citations Open access
Semantic Scholar
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC.
P. Bordi, M. Del Re, R. Minari, E. Rofi +14 more
2019Lung Cancer50 citations Open access
Semantic Scholar
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).
M. Imbimbo, M. Ottaviano, M. Vitali, A. Fabbri +78 more
2018Cancer Treatment Reviews50 citations Open access
Semantic Scholar
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
Filippo Martignano, Uday Munagala, S. Crucitta, A. Mingrino +5 more
2020Molecular Cancer47 citations Open access
Semantic Scholar
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology
I. Petrini, S. Barachini, V. Carnicelli, S. Galimberti +4 more
2016OncoTarget42 citations Open access
Semantic Scholar
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.
F. Cucchiara, I. Petrini, C. Romei, S. Crucitta +8 more
2021Pharmacological Research41 citations Open access
Semantic Scholar
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
M. Del Re, P. Bordi, E. Rofi, G. Restante +9 more
2018British Journal of Cancer41 citations Open access
Semantic Scholar
Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile?
V. Aprile, D. Bacchin, S. Korasidis, A. Nesti +6 more
2020Interactive Cardiovascular and Thoracic Surgery39 citations Open access
Semantic Scholar
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
M. Del Re, F. Cucchiara, E. Rofi, Lorenzo Fontanelli +12 more
2020Cancer Immunology and Immunotherapy37 citations Open access
Semantic Scholar
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
F. Cucchiara, M. Del Re, S. Valleggi, C. Romei +8 more
2020Frontiers in Oncology36 citations Open access
Semantic Scholar
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia
F. Guerrini, Matteo Paolicchi, F. Ghio, E. Ciabatti +12 more
2016Frontiers in Pharmacology33 citations Open access
Semantic Scholar
Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms
G. Fontanelli, C. Baratè, E. Ciabatti, F. Guerrini +9 more
2015International Journal of Laboratory Hematology30 citations
Semantic Scholar
Comparison of ddPCR and sdPCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.
S. Crucitta, M. Ruglioni, C. Novi, Mascia Manganiello +9 more
2023Clinica chimica acta; international journal of clinical chemistry29 citations Open access
Semantic Scholar
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.
M. Del Re, I. Petrini, F. Mazzoni, S. Valleggi +9 more
2019Clinical Lung Cancer28 citations
Semantic Scholar
Mesenchymal Stem Cell in Pancreatic Islet Transplantation
S. Barachini, L. Biso, Shivakumar Kolachalam, I. Petrini +3 more
2023Biomedicines26 citations Open access
Semantic Scholar
erbB in NSCLC as a molecular target: current evidences and future directions
M. Del Re, F. Cucchiara, I. Petrini, S. Fogli +6 more
2020ESMO Open25 citations Open access
Semantic Scholar
EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance.
S. Fogli, Beatrice Polini, M. Del Re, I. Petrini +4 more
2018Pharmacogenomics (London)25 citations
Semantic Scholar
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
Yosuke Yamada, Djeda Belharazem-Vitacolonnna, H. Bohnenberger, Christel Weiss +19 more
2022Cell Death and Disease24 citations Open access
Semantic Scholar
Thymectomy in myasthenic patients with thymoma: killing two birds with one stone.
V. Aprile, S. Korasidis, D. Bacchin, G. Petralli +4 more
2020Annals of Thoracic Surgery24 citations
Semantic Scholar
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results
V. Aprile, D. Bacchin, S. Korasidis, R. Ricciardi +3 more
2021Annals of Translational Medicine23 citations Open access
Semantic Scholar
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma
M. Imbimbo, M. Vitali, A. Fabbri, M. Ottaviano +15 more
2018Clinical Lung Cancer20 citations
Semantic Scholar
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report
M. Del Re, E. Rofi, C. Cappelli, G. Puppo +5 more
2019BMC Cancer17 citations Open access
Semantic Scholar
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas
I. Petrini, M. Lencioni, E. Vasile, L. Fornaro +14 more
2017Cancer Biomarkers17 citations Open access
Semantic Scholar
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
Efrat Katsman, Shari Orlanski, Filippo Martignano, Ilana Fox-Fisher +7 more
2022Genome Biology15 citations Open access
Semantic Scholar
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
M. Del Re, E. Vasile, A. Falcone, R. Danesi +1 more
2014Expert Review of Molecular Diagnostics15 citations
Semantic Scholar
Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management
S. Barachini, G. Buda, I. Petrini
2024Journal of Clinical Medicine14 citations Open access
Semantic Scholar
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment
M. Del Re, P. Bordi, I. Petrini, E. Rofi +13 more
2017OncoTarget14 citations Open access
Semantic Scholar
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results
R. Fazzi, I. Petrini, N. Giuliani, R. Morganti +5 more
2021Frontiers in Immunology13 citations Open access
Semantic Scholar
GTF2I Mutations Are Common in Thymic Epithelial Tumors But Not in Hematological Malignancies.
G. Tarrini, E. Ciabatti, S. Pacini, S. Galimberti +1 more
2017Anticancer Research13 citations Open access
Semantic Scholar
Human adult mesangiogenic progenitor cells reveal an early angiogenic potential, which is lost after mesengenic differentiation
M. Montali, F. Panvini, S. Barachini, F. Ronca +4 more
2017Stem cell research & therapeutics13 citations Open access
Semantic Scholar
Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients
Giulia Pasquini, E. Vasile, C. Caparello, C. Vivaldi +5 more
2016Oncology13 citations
Semantic Scholar
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach
I. Petrini, M. Sollini, F. Bartoli, S. Barachini +4 more
2022Cancers11 citations Open access
Semantic Scholar
A phase II (PhII) trial of sorafenib (S) in combination with 5-fluorouracil (5FU) continuous infusion (c.i.) in patients (pts) with advanced hepatocellular carcinoma (HCC): Preliminary data.
I. Petrini, M. Lencioni, Miriam Ricasoli, M. Iannopollo +6 more
2016Journal of Clinical Oncology11 citations
Semantic Scholar
Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas
S. Barachini, Eleonora Pardini, I. S. Burzi, Gisella Sardo Infirri +2 more
2023Cancers10 citations Open access
Semantic Scholar
Somatic mutations of thymic epithelial tumors with myasthenia gravis
Eleonora Pardini, F. Cucchiara, S. Palumbo, G. Tarrini +11 more
2023Frontiers in Oncology9 citations Open access
Semantic Scholar
Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations
I. Petrini, G. Giaccone
2022OncoTargets and Therapy9 citations Open access
Semantic Scholar
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patients
Giulia Pasquini, C. Menichelli, G. Pastore, F. Casamassima +10 more
2021Journal of Thoracic Disease9 citations Open access
Semantic Scholar
Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow
M. Montali, S. Barachini, F. Panvini, V. Carnicelli +3 more
2016Front. Cell Dev. Biol.9 citations Open access
Semantic Scholar
L32Single-centre experience with third-line chemotherapy with irinotecan plus 5-fluorouracil and leucovorin (FOLFIRI) in metastatic gastric cancer patients
Giulia Pasquini, L. Fornaro, E. Vasile, M. Lencioni +5 more
20159 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Del Re×20
Invite
M. Del Re — researcher profile on SciRah
R. Danesi×19
Invite
R. Danesi — researcher profile on SciRah
S. Crucitta×15
Invite
S. Crucitta — researcher profile on SciRah
E. Rofi×11
Invite
E. Rofi — researcher profile on SciRah

×10

Invite

A. Chella — researcher profile on SciRah

Invite

G. Restante — researcher profile on SciRah

S. Barachini×8

Invite

S. Barachini — researcher profile on SciRah

Invite

E. Vasile — researcher profile on SciRah

Invite

A. Falcone — researcher profile on SciRah

F. Cucchiara×7

Invite

F. Cucchiara — researcher profile on SciRah

Invite

M. Lucchi — researcher profile on SciRah

Giulia Pasquini×6

Invite

Giulia Pasquini — researcher profile on SciRah